An Approach for Determining Antibiotic Loading for a Physician-directed Antibiotic-loaded PMMA Bone Cement Formulation
- 411 Downloads
When a physician-directed antibiotic-loaded polymethylmethacrylate (PMMA) bone cement (ALBC) formulation is used in total hip arthroplasties (THAs) and total knee arthroplasties (TKAs), current practice in the United States involves arbitrary choice of the antibiotic loading (herein defined as the ratio of the mass of the antibiotic added to the mass of the cement powder). We suggest there is a need to develop a rational method for determining this loading.
We propose a new method for determining the antibiotic loading to use when preparing a physician-directed ALBC formulation and illustrate this method using three in vitro properties of an ALBC in which the antibiotic was daptomycin.
Materials and Methods
Daptomycin was blended with the powder of the cement using a mechanical mixer. We performed fatigue, elution, and activity tests on three sets of specimens having daptomycin loadings of 2.25, 4.50, and 11.00 wt/wt%. Correlational analyses of the results of these tests were used in conjunction with stated constraints and a nonlinear optimization method to determine the daptomycin loading to use.
With an increase in daptomycin loading, the estimated mean fatigue limit of the cement decreased, the estimated elution rate of the antibiotic increased, and the percentage inhibition of staphylococcal growth by the eluate remained unchanged at 100%. For a daptomycin-loaded PMMA bone cement we computed the optimum amount of daptomycin to mechanically blend with 40 g of cement powder is 1.36 g.
We suggest an approach that may be used to determine the amount of antibiotic to blend with the powder of a PMMA bone cement when preparing a physician-directed ALBC formulation, and highlighted the attractions and limitations of this approach.
When a physician-directed ALBC formulation is selected for use in a TKA or THA, the approach we detail may be employed to determine the antibiotic loading to use rather than the empirical approach that is taken in current clinical practice.
KeywordsPMMA Fatigue Life Tobramycin Bone Cement Fatigue Limit
We thank Cubist Pharmaceuticals and Wright Medical Technology for generous donation of the daptomycin and the bone cement, respectively, used in this investigation and Dr. Teong Tan for help with the optimization work.
- 1.American Society for Testing and Materials (ASTM). Standard F 2118-03: Standard test method for constant amplitude of force controlled fatigue testing of acrylic bone cement materials. In: Annual Book of ASTM Standards 2008, Vol 13.01. West Conshohocken, PA: ASTM International; 2008:1136–1143.Google Scholar
- 2.Australian Orthopaedics Association. National Joint Replacement Registry. Annual Report. Adelaide, Australia: AOA; 2009:169–177.Google Scholar
- 7.Dunne N, Hill J, McAfee P, Todd K, Kirkpatrick R, Tunney M, Patrick S. In vitro study of the efficacy of acrylic bone cement loaded with supplementary amounts of gentamicin: effects on mechanical properties, antibiotic release, and biofilm formation. Acta Orthop. 2007;78:774–785.CrossRefPubMedGoogle Scholar
- 9.He S, Scott C, Higham P. Mixing of acrylic bone cement: effect of oxygen on setting properties. Biomaterials. 2003;30:202–209.Google Scholar
- 11.Jasty M, Moloney WJ, Bragdon CR, O’Connor D, Haire T, Harris WH. The initiation of failur e in cemented femoral components of hip arthroplasties. J Bone Joint Surg. 1991;73:551–558.Google Scholar
- 23.Livermore DM. Future directions with daptomycin. J Antimicrob Chemother. 2008;62(Suppl 3):iii41–iii49.Google Scholar
- 27.Schittkowski K. NLPQL: a Fortran subroutine solving constrained nonlinear programming problems. Annals Oper Res. 1986;5:485–500.Google Scholar
- 28.Shackelford JF. Introduction to Materials Science for Engineers. 6th ed. Upper Saddle River, NJ: Pearson Prentice Hall; 2005.Google Scholar